MedTrace Logo

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder

NCT00351910 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 494

Last updated 2011-01-26

No results posted yet for this study

Summary

To evaluate the efficacy of quetiapine fumarate sustained release (Seroquel SR™) in combination with an antidepressant versus an antidepressant alone in patients with Major Depressive Disorder.

PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Conditions

Interventions

DRUG

Quetiapine

DRUG

Amitriptyline

DRUG

Bupropion

DRUG

Citalopram

DRUG

Duloxetine

DRUG

Escitalopram

DRUG

Fluoxetine

DRUG

Paroxetine

DRUG

Sertraline

DRUG

Venlafaxine

Sponsors & Collaborators

Principal Investigators

  • Seroquel Medical Science Director, MD · AstraZeneca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Completion
2007-04-30

Countries

  • Australia
  • Belgium
  • Canada
  • Czechia
  • Finland
  • France
  • Germany
  • Norway
  • Poland
  • Romania
  • South Africa
  • Sweden

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00351910 on ClinicalTrials.gov